I will convene our meeting number 112.
Welcome to our guests. We appreciate your taking the time to share your wisdom with us. We look forward to hearing from you.
Today we have Catherine Parker, Director General, Biologics and Genetic Therapies Directorate, Health Products and Food Branch at the Department of Health. We have Karen Reynolds, Executive Director, Office of Pharmaceuticals Management Strategies; and Dr. John Patrick Stewart, Director General, Therapeutic Products Directorate.
I believe you've been here before, have you not, in this Parliament?